中医药治疗高脂血症的临床研究进展

Progress in Clinical Research of Chinese Medicine Treatment of Hyperlipidemia

随着社会的不断进步,人们的生活水平逐渐提高,饮食结构发生明显改变,致我国高脂血症的患病率明显升高。据2014年血脂异常流行病学Meta分析研究结果显示:我国18岁以上人群中高胆固醇血症的患病率为7.9%,高甘油三酯血症的患病率为13.7%,高低密度脂蛋白胆固醇血症的患病率为7.6%,低高密度脂蛋白胆固醇血症的患病率为11.0%[1]。我国血脂达标情况最新调查结果显示,高脂血症治疗率仅有39%,其中仅25.8%的高脂血症患者血脂达标。目前,我国高脂血症正在面临着高患病率、低治疗率与低控制率的现状。现代研究表明,高脂血症是导致动脉粥样硬化、高血压、冠心病等心脑血管疾病的最重要的因素之一,是缺血性心脏病、脑卒中的独立危险因素。

As society progresses,peoples living standards gradually improved,the occurrence of significant changes in diet,cause of hyperlipidemia prevalence increased significantly.According to the 2014 dyslipidemia epidemiological studies Meta-analysis showed that：people over the age of 18 hypercholesterolemia prevalence of 7.9%, hypertriglyceridemia prevalence of 13.7%, high densitylipoprotein hypercholesterolemia prevalence of 7.6%,1ow high-density lipoprotein cholesterol prevalence rate of 11.0%.Lipid Status of the latest survey results show that the treatment of hyperlipidemia was only 39%,of which only 25.8% of patients with hyperlipidemia lipid standards. At present,China is facing the current situation hyperlipidemia high prevalence,low treatment rate and low control rates. Modern research shows that hyperlipidemia is a result of atherosclerosis,one of the most important factors for hypertension,coronary heart disease and other cardiovascular and cerebrovascular disease,it is an independent risk factor for ischemic heart disease,stroke.